Published in PLOS Biology · View the paper (DOI)
Researchers at Boston Children's Hospital developed a new version of botox B with improved binding to nerves, leading to more effective paralysis, longer-lasting results, and reduced systemic toxicity. The enhanced toxin showed higher therapeutic efficacy and better safety range in a mouse model.
Coverage from 2 institutions
- Building a better botox Boston Children's Hospital · Mar 17, 2020 · first to report
- Engineered botox is more potent and safer in mice PLOS · Mar 17, 2020